(19)

(11)

EP 4 799 166 A1

(12)

(43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24801456.5 (22) Date of filing: 24.10.2024

(51) International Patent Classification (IPC):  G16B 25/10(2019.01) G16B 40/30(2019.01) G16B 40/20(2019.01) G16H 50/20(2018.01) (52) Cooperative Patent Classification (CPC): G16B 25/10; G16H 50/20; G16B 40/30; G16B 40/20 (86) International application number: PCT/US2024/052762 (87) International publication number: WO 2025/090733 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 27.10.2023 EP 23315401 (71) Applicant: Sanofi 75017 Paris (FR)	(72) Inventors: XING, Heming Cambridge, Massachusetts 02141 (US) DE RINALDIS, Emanuele Cambridge, Massachusetts 02141 (US) DU, Zhou Cambridge, Massachusetts 02141 (US) (74) Representative: McDougall, James et al Venner Shipley LLP TIDE Bankside 8 Emerson Street London SE1 9DU London SE1 9DU (GB)